Recent Finacing
Recent Raise
Altheus Therapeutics develops Zoenasa, combining mesalamine and antioxidant, with a rectal gel (phase 1 safety complete, phase 2 planned) for left-sided colitis and an oral controlled-release for proximal colitis.
Focus Areas
Total Raised
Funding round